服务热线
Anti-CXCL1/CXCL2/CXCL3/CXCL5/CXCL6/CXCL7/CXCL8 mAbs [Eltrekibart Biosimilar] (MABL-4637)
Anti-SIGLEC3/CD33/p67;CD3E mAbs [Eluvixtamab Biosimilar] (MABL-4638)
Anti-CSF1R/CD115/M-CSFR mAbs [Emactuzumab Biosimilar] (MABL-4639)
Anti-IFNG mAbs [Emapalumab Biosimilar] (MABL-4640)
Anti-SIGLEC3/CD33/p67;CD3E mAbs [Emerfetamab Biosimilar] (MABL-4641)
Anti-CD3E;CD19 mAbs [Emfizatamab1 Biosimilar] (MABL-4642)
Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Emfizatamab2 Biosimilar] (MABL-4643)
Anti-F9;F10 mAbs [Emicizumab Biosimilar] (MABL-4644)
Anti-MET/HGFR mAbs [Emibetuzumab Biosimilar] (MABL-4645)
Anti-VTCN1/B7H4 mAbs [Emiltatug Biosimilar] (MABL-4646)
Anti-FLT3/CD135/FLK2;CD3E mAbs [Emirodatamab Biosimilar] (MABL-4647)
Anti-C2 mAbs [Empasiprubart Biosimilar] (MABL-4648)
Anti-TMEM219/IGFBP-3R mAbs [Ebrasodebart Biosimilar] (MABL-4617)
Anti-C3d mAbs [Ebribafusp Biosimilar] (MABL-4618)
Anti-PCSK9 mAbs [Ebronucimab Biosimilar] (MABL-4619)
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn
陕ICP备2021006339号
![Anti-CXCL1/CXCL2/CXCL3/CXCL5/CXCL6/CXCL7/CXCL8 mAbs [Eltrekibart Biosimilar] (MABL-4637)](/uploads/allimg/2025/11/02/3fe156ffb49b3bc637b9dbe16635b5e9.png)
![Anti-TMEM219/IGFBP-3R mAbs [Ebrasodebart Biosimilar] (MABL-4617)](/uploads/allimg/2025/11/02/66555efe2ec937c5ec76319a069329a8.png)